Hap Trading, LLC Sage Therapeutics, Inc. Transaction History

Hap Trading, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$37.06 - $47.11 $17,418 - $22,141	-470 Reduced 3.04%	14,982 $637,000
Q4 2020 Feb 16, 2021	SELL	$58.41 - $89.06 $1.09 Million - $1.66 Million	-18,610 Reduced 54.64%	15,452 $1.34 Million
Q3 2019 Nov 12, 2019	BUY	$140.29 - $189.96 $4.78 Million - $6.47 Million	34,062 New	34,062 $4.78 Million

218

46.4M

847K

188K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $340M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.